When a Dupuytren's contracture reaches the point of needing intervention, three modern options exist: collagenase (Xiaflex) injection, percutaneous needle aponeurotomy (PNA), and open fasciectomy. Each has its place. Each has trade-offs in invasiveness, recovery time, and recurrence rate. The right choice depends on the specific cord pattern, the joints involved, prior treatment, and patient factors. This article explains how each approach works and how a hand surgeon thinks about choosing among them.
Why Treat Dupuytren's at All
Dupuytren's contracture is a fibroproliferative disease of the palmar fascia. Painless cords develop under the skin of the palm and fingers, gradually pulling the affected fingers into flexion. Most patients live with mild Dupuytren's for years without intervention. Treatment becomes appropriate when the contracture interferes with daily life: cannot lay the hand flat on a table (the Hueston tabletop test), cannot put the hand in a pocket, cannot shake hands comfortably, cannot wash the face.
The disease has no cure. Treatment addresses the active contracture and improves finger extension, but the underlying biology persists. Recurrence is common across all three treatment modalities. The decision is not whether the disease will recur but how invasively to treat the current contracture.
Option 1: Xiaflex (Collagenase) Injection
Collagenase clostridium histolyticum (brand name Xiaflex) is an enzyme that digests collagen, the structural protein in the Dupuytren's cord. The procedure is two visits:
- Visit 1 (Injection): the surgeon identifies a palpable cord and injects Xiaflex directly into it. The injection takes about 5 minutes. The patient leaves with a small dressing.
- Visit 2 (Manipulation): 24 to 72 hours later, the patient returns. Local anesthetic is injected, and the surgeon manually extends the affected finger, breaking the now-weakened cord. An audible pop is sometimes felt. The finger straightens immediately.
Xiaflex is best suited to:
- A discrete palpable cord, particularly at the MCP joint
- Patients who prefer office-based treatment without surgery
- Single-finger contractures
Recovery is short. A soft night extension splint for 4 to 8 weeks, gradual return to activity over 1 to 2 weeks. Mild bruising and swelling for 1 to 2 weeks. Skin tears can occur with the manipulation in 5 to 10 percent of cases and heal with simple wound care. Most patients return to typing within days and full activity within 1 to 2 weeks.
Recurrence at 5 years is approximately 50 to 70 percent. The cord can re-form even after enzyme dissolution because the underlying biology persists.
A short post from Dr. Loredo on Dupuytren's contracture. View on Instagram.
Option 2: Percutaneous Needle Aponeurotomy (PNA)
PNA uses a small needle or fine blade to repeatedly puncture and weaken the cord through the skin. After several passes, the surgeon manually extends the finger, breaking the now-perforated cord. The procedure is done in the office under local anesthesia.
PNA candidates are similar to Xiaflex candidates: discrete palpable cords, MCP joint contractures, single-finger involvement. PNA is sometimes preferred when Xiaflex is unavailable or contraindicated, when the patient cannot return for the manipulation visit a few days later, or when the surgeon prefers a needle-based technique.
Recovery is similar to Xiaflex: soft splint at night, gradual return to activity, mild bruising. Skin tears can occur with the manipulation. Recurrence at 5 years is approximately 50 to 60 percent.
Option 3: Open Fasciectomy
Open fasciectomy is the traditional surgical treatment. The diseased palmar fascia is exposed through a zigzag incision (Brunner) and removed under direct vision. Healthy fascia is preserved. The skin is closed primarily, sometimes with a Z-plasty to lengthen the incision and prevent contracture of the scar.
Open fasciectomy is preferred for:
- Severe contractures, particularly with PIP joint involvement (which often requires direct visualization to fully release)
- Recurrent disease after prior Xiaflex or PNA treatment
- Cases with diffuse fascial involvement rather than a discrete cord
- Cases with associated nerve or vessel encasement that requires careful dissection
- Patients who prefer a one-time more durable treatment over multiple less-invasive interventions
Recovery is longer than the office-based options: 4 to 6 weeks of splinting (custom hand-based extension splint), 6 to 12 weeks of structured hand therapy with active and passive range of motion exercises. Wound healing is the rate-limiting step in early recovery. Most patients return to office work within 2 to 4 weeks and full activity by 8 to 12 weeks.
The trade-off is durability. Recurrence at 5 years is 20 to 40 percent, lower than the office-based options. The longer recovery is the price for the lower recurrence rate.
How to Choose
The decision is shared between the surgeon and the patient based on:
- Joint involvement: isolated MCP contracture often does well with Xiaflex or PNA. PIP joint contracture often does better with open fasciectomy.
- Cord pattern: a discrete palpable cord favors enzyme or needle. A diffuse fascial fibrosis without a clear cord favors open surgery.
- Prior treatment: recurrence after a previous Xiaflex or PNA often warrants open fasciectomy for the second treatment.
- Patient priorities: a patient who needs to return to work in 1 week is better served by Xiaflex or PNA. A patient who can take 4 to 6 weeks of recovery for lower recurrence may prefer open fasciectomy.
- Severity: mild to moderate contracture is well treated by any approach. Severe contracture (greater than 30 to 45 degrees at the MCP, especially with PIP involvement) often does better with open fasciectomy.
- Surgeon experience: Dr. Loredo offers all three approaches. Surgeons who lean heavily toward one approach often have better outcomes with that approach. Choosing the right surgeon for the chosen approach matters.
Realistic Expectations
None of the three options cure Dupuytren's contracture. The disease persists at the cellular level. Recurrence is common across all three modalities. The differences are in invasiveness, recovery time, and the rate of recurrence over 5 to 10 years.
Most patients have a successful first treatment regardless of which option is chosen. Many patients have multiple lifetime treatments as the disease progresses or recurs. Each new treatment can be the same or a different option, depending on the situation. A patient might have Xiaflex for the first contracture in the ring finger, PNA for a recurrence, and open fasciectomy for an aggressive new contracture in the small finger.
The most important shift in mindset for Dupuytren's patients is that this is a chronic disease being managed over a lifetime, not a single problem being cured by a single intervention.
Frequently Asked Questions
What is Xiaflex and how does it work?
Xiaflex (collagenase clostridium histolyticum) is an enzyme that digests collagen, the structural protein that makes up the Dupuytren's cord. The enzyme is injected directly into the cord during an office visit. The patient returns 24 to 72 hours later, and the surgeon manipulates the affected finger to break the now-weakened cord. Most patients see immediate improvement in finger extension. Recovery is short: a soft splint at night for a few weeks and gradual return to activity over 1 to 2 weeks.
What is needle aponeurotomy?
Percutaneous needle aponeurotomy (PNA), also called needle fasciotomy, uses a small needle (or sometimes a fine blade) to repeatedly puncture and weaken the Dupuytren's cord through the skin. The cord is then manually broken to straighten the finger. The procedure is done in the office under local anesthesia. Recovery is similar to Xiaflex with a soft splint and gradual return. PNA does not require an enzyme and is sometimes preferred when Xiaflex is unavailable or contraindicated.
When is open surgery needed?
Open fasciectomy is the most invasive option and is reserved for severe contractures, recurrent disease after prior injection or needle treatment, PIP joint involvement (which often requires direct visualization to release), and cases with associated nerve or vessel encasement. The procedure removes the diseased fascia rather than just breaking the cord, which produces lower recurrence rates than the less invasive options. Recovery is longer: 4 to 6 weeks of splinting and 6 to 12 weeks of hand therapy.
What about recurrence rates?
Dupuytren's contracture has a high tendency to recur because the underlying biology of the disease persists. Recurrence rates at 5 years are approximately 50 to 70 percent for Xiaflex injection, 50 to 60 percent for needle aponeurotomy, and 20 to 40 percent for open fasciectomy. Patients with strong family history, early-onset disease, or aggressive contracture patterns have higher recurrence rates regardless of treatment choice. Repeat treatment is feasible with all three options when recurrence occurs.
Related Reading
- Dupuytren's Contracture: full condition page covering disease biology, evaluation, and the treatment ladder.
- Early Signs of Carpal Tunnel: nerve symptoms can coexist with Dupuytren's, particularly in patients with diabetes.
- General Hand and Elbow Pain: triage page that helps identify when to seek evaluation.
- Call Us: schedule a Dupuytren's evaluation.